Description |
Product Type |
Product Size |
Syrup |
1'S |
Product Company |
Sandoz |
Pizotifen 60ml |
Product Type |
Product Size |
Drops |
1'S |
Product Company |
ICI Pakistan |
Nystatin 50ml |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Sandoz |
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Aqvida |
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Sandoz |
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Pfizer
|
Cisplatin 50mg
|
Content | Pizotifen belongs to the class of antamines and is related to cyproheptadine. It is a potent serotonin and tryptamine antagonist that has been used for migraine prevention for many years. | Nystatin is an antifungal medicine and not an antibiotic. It makes holes in the cell membrane of the fungus and the contents leak out. This kills the fungus and treats the infection. If you're taking nystatin to prevent an infection, the medicine kills any fungus as it starts to appear.
| Oxaliplatin is a platinum based chemotherapy agent used to treat carcinoma of the colon or rectum or stage III colon cancer. | Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. | Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. | Cisplatin is a platinum based chemotherapy agent used to treat various sarcomas, carcinomas, lymphomas, and germ cell tumors. |
Reviews
There are no reviews yet.